ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 294 filers reported holding ICU MED INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $833,427 | -35.9% | 7,003 | -4.0% | 0.00% | – |
Q2 2023 | $1,300,431 | -23.5% | 7,298 | -29.1% | 0.00% | – |
Q1 2023 | $1,699,088 | -23.5% | 10,300 | -27.0% | 0.00% | – |
Q4 2022 | $2,220,468 | -3.0% | 14,100 | -7.2% | 0.00% | – |
Q3 2022 | $2,289,000 | -19.1% | 15,200 | -11.7% | 0.00% | -100.0% |
Q2 2022 | $2,828,000 | -57.1% | 17,206 | -41.9% | 0.00% | 0.0% |
Q1 2022 | $6,598,000 | -74.5% | 29,633 | -72.8% | 0.00% | -83.3% |
Q4 2021 | $25,831,000 | -3.2% | 108,841 | -4.8% | 0.01% | +20.0% |
Q3 2021 | $26,678,000 | -40.1% | 114,311 | -47.2% | 0.01% | -50.0% |
Q2 2021 | $44,574,000 | +6.8% | 216,589 | +6.7% | 0.01% | 0.0% |
Q1 2021 | $41,717,000 | +108.6% | 203,064 | +117.8% | 0.01% | +100.0% |
Q4 2020 | $20,001,000 | +516.7% | 93,249 | +425.6% | 0.01% | +400.0% |
Q3 2020 | $3,243,000 | -32.6% | 17,743 | -32.0% | 0.00% | -50.0% |
Q2 2020 | $4,811,000 | -95.2% | 26,104 | -94.7% | 0.00% | -95.6% |
Q1 2020 | $99,333,000 | +23.1% | 492,308 | +14.1% | 0.04% | +28.6% |
Q4 2019 | $80,718,000 | +97.8% | 431,370 | +68.7% | 0.04% | +84.2% |
Q3 2019 | $40,816,000 | +1054.6% | 255,741 | +1722.3% | 0.02% | +850.0% |
Q2 2019 | $3,535,000 | +190.7% | 14,034 | +176.3% | 0.00% | +100.0% |
Q1 2019 | $1,216,000 | -79.5% | 5,079 | -80.3% | 0.00% | -66.7% |
Q4 2018 | $5,933,000 | -65.3% | 25,836 | -57.2% | 0.00% | -62.5% |
Q3 2018 | $17,085,000 | +131.7% | 60,425 | +140.6% | 0.01% | +100.0% |
Q2 2018 | $7,375,000 | +2031.5% | 25,117 | +1733.4% | 0.00% | – |
Q1 2018 | $346,000 | -96.8% | 1,370 | -97.2% | 0.00% | -100.0% |
Q4 2017 | $10,712,000 | -40.9% | 49,594 | -49.2% | 0.01% | -50.0% |
Q3 2017 | $18,135,000 | +3264.6% | 97,579 | +2661.9% | 0.01% | – |
Q1 2017 | $539,000 | -73.5% | 3,533 | -74.4% | 0.00% | -100.0% |
Q4 2016 | $2,034,000 | +16.8% | 13,804 | +0.2% | 0.00% | 0.0% |
Q3 2016 | $1,741,000 | -65.7% | 13,778 | -69.4% | 0.00% | -66.7% |
Q2 2016 | $5,074,000 | +52.9% | 45,000 | +41.2% | 0.01% | +50.0% |
Q1 2016 | $3,318,000 | -36.6% | 31,873 | -31.3% | 0.00% | -33.3% |
Q4 2015 | $5,231,000 | -26.4% | 46,375 | -28.5% | 0.01% | -14.3% |
Q3 2015 | $7,103,000 | +98.4% | 64,867 | +68.8% | 0.01% | +133.3% |
Q1 2015 | $3,580,000 | +77.0% | 38,429 | +55.6% | 0.00% | +50.0% |
Q4 2014 | $2,023,000 | +48.8% | 24,692 | +16.6% | 0.00% | +100.0% |
Q3 2014 | $1,360,000 | -14.6% | 21,170 | -19.1% | 0.00% | -50.0% |
Q2 2014 | $1,592,000 | +80.1% | 26,172 | +77.3% | 0.00% | +100.0% |
Q1 2014 | $884,000 | -59.4% | 14,762 | -56.8% | 0.00% | -66.7% |
Q4 2013 | $2,178,000 | +87.0% | 34,204 | +99.4% | 0.00% | +50.0% |
Q3 2013 | $1,165,000 | +257.4% | 17,152 | +279.2% | 0.00% | +100.0% |
Q2 2013 | $326,000 | – | 4,523 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |